Therapeutic implications of the intestinal microflora.
D000818:Animals; D001419:Bacteria / Q000378:metabolism; D001711:Biotransformation; D002396:Catechols / Q000378:metabolism; D002934:Cinnamates / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004358:Drug Therapy; D004463:Ecology; D005243:Feces / Q000032:analysis / Q000382:microbiology; D005544:Forecasting; D005856:Germ-Free Life; D006801:Humans; D007422:Intestines / Q000382:microbiology*; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D051381:Rats; D012460:Sulfasalazine / Q000378:metabolism / Q000652:urine; D013559:Symbiosis; D013812:Therapeutics
D002396:Catechols; D002934:Cinnamates; D004364:Pharmaceutical Preparations; D012460:Sulfasalazine; D004295:Dihydroxyphenylalanine